The section of the monograph outlines crucial requirements for the manufacturing process. It mandates that tablets possess a suitable mechanical strength to avoid crumbling or breaking during handling and subsequent processing. This can be demonstrated using tests described in general chapters 2.9.7. Friability of uncoated tablets and 2.9.8. Resistance to crushing of tablets . Furthermore, the monograph requires suitable measures to be taken during manufacture, packaging, storage, and distribution to ensure the microbiological quality of the tablets, referencing general chapter 5.1.4. Microbiological quality of non-sterile pharmaceutical preparations and substances for pharmaceutical use .
: Manufacturers must take rigorous preventative measures to prevent contamination during processing, storage, and cross-border distribution, adhering directly to the guidelines set in Ph. Eur. General Chapter 5.1 .
The European Pharmacopoeia (Ph. Eur.) monograph for Tablets (0478) provides a comprehensive set of specifications for the testing and evaluation of tablets. The monograph covers a range of requirements, including appearance, average weight, uniformity of weight, hardness, friability, disintegration, and dissolution. By following these specifications, manufacturers can ensure that their tablets meet the necessary standards for quality, purity, and strength. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-
To comply with Monograph 0478, finished batches of tablets must undergo specific cross-referenced general tests. These tests ensure physical and chemical uniformity across the production lot. A. Uniformity of Dosage Units (2.9.40)
One of the most vital safety checks, this test ensures that every individual tablet contains the intended amount of API within strict tolerances. Compliance can be demonstrated via: The section of the monograph outlines crucial requirements
: This ensures that each tablet contains the correct amount of active substance. This is typically measured through Uniformity of Mass (2.9.5) Uniformity of Content (2.9.6) Dissolution (2.9.3)
: Formulated with carbonates to react in water and release carbon dioxide for rapid dispersion. Friability of uncoated tablets and 2
Mandatory for tablets with low doses of API (e.g., less than 25 mg or less than 25% of the total mass), requiring individual chemical assays of a specified number of tablets. B. Dissolution (2.9.3)